Dear Clients & Partners,
The spread of the COVID-19 virus has created an unprecedented challenge to the global community, and in particular, the healthcare industry. Many of the professionals that we work with every day are now on the front lines of the battle to contain the outbreak and treat patients.
Read moreWe are pleased to have recently received clearance from the U.S. Food and Drug Administration (FDA) to market our Expandable Stand-Alone VariLift® systems for use with allograft.
Wenzel Spine’s VariLift® Platforms Now Provide the Broadest Clearance of an Expandable Interbody Fusion Device on the Market.
When expanded, the large fenestrations of our VariLift® devices allow for maximum bone to graft contact as well as overpacking the disc space with graft material post implantation and expansion. This new FDA clearance will give surgeons more options in sourcing the graft tissue that meets their patients specific needs. Check out the video below to see the VariLift®-LX graft chamber in action.
Read moreWenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced a 24 Consecutive Patient Case Series detailing an endoscopic, stand-alone TLIF surgical technique used with the VariLift-LX System has been published in the Journal of Spine, Volume 7, Issue 2.
Read moreDr. Jeffery Arle Brings Cervical Fusion Expertise
Austin, TX – March 27, 2018 - Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced the expansion of its Scientific Advisory Board with the addition of Jeffery Arle, MD, PhD. The board comprises a group of world-class surgeons who facilitate the company’s ongoing efforts to develop and deliver leading MIS solutions.
Read more